This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Daniel Chu
Process Development Manager at Kinovate Life Sciences
Speaker

Profile

Daniel Chu is a Process Development Manager at Kinovate Life Sciences, a wholly owned subsidiary of Nitto, where he has worked for nearly eight years. Formerly a Quality Control Manager, Daniel brings experience across analytical testing, process development, and product support. In his current role, he oversees process and analytical development for ligand-loaded solid supports used in solid-phase oligonucleotide synthesis, namely products based on the NittoPhase scaffold. His work focuses on product quality, process economy, and practical manufacturability, including the development and refinement of processes and analytical methods for both established products and custom ligand chemistries

Agenda Sessions

  • NittoPhase™ SL: A High-Functional-Density Solid Support for Short-Mer Oligonucleotide Production

    1:05pm